Raja'a Al-Attiyah

Prof. Raja'a Al-Attiyah


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

31 August 2004 in Clinical and Experimental Immunology
Verified
Journal Article
Closed access
PDF file
RARaja'a Al-Attiyah
Raja'a Al-Attiyah
AMA. S. Mustafa
A. S. Mustafa
AAA. T. Abal
A. T. Abal
AEA. S. M. El‐Shamy
A. S. M. El‐Shamy
WDW. Dalemans
W. Dalemans
YSY. A. W. Skeiky
Y. A. W. Skeiky

1 September 2008 in Infection and Immunity
Verified
Journal Article
Closed access
RARaja'a Al-Attiyah
Raja'a Al-Attiyah
AMA. S. Mustafa
A. S. Mustafa
Comparative genomics has identified several regions of differences (RDs) between the infectiousMycobacterium tuberculosisand the vaccine strains ofMycobacterium bovisBCG. We aimed to evaluate the cellular immune responses induced by antigens encoded by genes predicted in 11 RDs. Synthetic peptides covering the sequences of RD1, RD4 to RD7, RD9 to RD13, and RD15 were tested for antigen-induced proliferation and secretion of Th1 cytokine, gamma interferon (IFN-γ), by peripheral blood mononuclear cells (PBMC) obtained from culture-proven pulmonary tuberculosis (TB) patients andM. bovisBCG-vaccinated healthy subjects. Among the peptide pools, RD1 induced the best responses in both donor groups and in both assays. In addition, testing of TB patients' PBMC for secretion of proinflammatory cytokines (tumor necrosis factor alpha [TNF-α], interleukin 6 [IL-6], IL-8, and IL-1β), Th1 cytokines (IFN-γ, IL-2, and TNF-β), and Th2 cytokines (IL-4, IL-5, and IL-10) showed differential effects of RD peptides in the secretion of IFN-γ and IL-10, with high IFN-γ/IL-10 ratios (32 to 5.0) in response to RD1, RD5, RD7, RD9, and RD10 and low IFN-γ/IL-10 ratios (<1.0) in response to RD12, RD13, and RD15. Peptide-mixing experiments with PBMC from healthy subjects showed that secretion of large quantities of IL-10 in response to RD12 and RD13 correlated with inhibition of Th1 responses induced by RD1 peptides. In conclusion, our results suggest thatM. tuberculosisRDs can be divided into two major groups—one group that activates PBMC to preferentially secrete IFN-γ and another group that activates preferential secretion of IL-10—and that these two groups of RDs may have roles in protection against and pathogenesis of TB, respectively.

1 January 2013 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
KOKhaled Orabi
Khaled Orabi
MAMohamed Salah Abaza
Mohamed Salah Abaza
Khalid El SayedKhalid El Sayed
Khalid El Sayed
AEAhmed Y Elnagar
Ahmed Y Elnagar
RARaja'a Al-Attiyah
Raja'a Al-Attiyah
RGRadhika P Guleri
Radhika P Guleri
It has been shown that proteasome inhibition leads to growth arrest in the G1 phase of the cell cycle and/or induction of apoptosis. However, it was found that some of these inhibitors do not induce apoptosis in several human normal cell lines. This selective activity makes proteasome inhibition a promising target for new generation of anticancer drugs. Clinical validation of the proteasome, as a therapeutic target in oncology, has been provided by the dipeptide boronic acid derivative; bortezomib. Bortezomib has proven to be effective as a single agent in multiple myeloma and some forms of non-Hodgkin’s lymphoma. Syringic acid (4-hydroxy-3,5-dimethoxybenzoic acid, 1), a known phenolic acid, was isolated from the methanol extract of Tamarix aucheriana and was shown to possess proteasome inhibitory activity.

1 October 2020 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
MRMaysoun Al Rushood
Maysoun Al Rushood
AAAmal Al-Eisa
Amal Al-Eisa
RARaja'a Al-Attiyah
Raja'a Al-Attiyah
Background: Urinary tract infection (UTI) is common in pediatrics. Infection of the upper urinary tract may cause renal scarring, and subsequently renal failure and hypertension. Permanent renal damage has been suggested to be caused by the host inflammatory response. Therefore, it is crucial to understand the host defense mechanisms against such infection in order to make timely diagnosis. The aim of this study was to evaluate interleukin-6 (IL-6) and IL-8 as potential biomarkers in differentiating acute pyelonephritis (AP) from cystitis (Cys) in children. Methods: Forty-three children (21 with AP and 22 with Cys) were included. Serum and urinary IL-6 and IL-8 were measured during the acute phase (within 12 hours of presentation) and the convalescent phase (8 weeks post-infection). Thirty-eight healthy children were included as controls. Results: During the acute phase, the mean urinary IL-6 level in the Cys group was significantly higher than that in the controls (17.8 pg/mL vs 14.8 pg/mL, P=0.03), while the serum levels were significantly higher in both the Cys and AP groups than in the controls (19.5 pg/mL, 19.4 pg/mL, 15 pg/mL, P=0.005 and 0.02, respectively). During the convalescent phase, serum and urinary IL-6 levels were higher in patients than in controls. Urinary IL-8 levels were significantly higher in both the AP and Cys groups compared to controls (206.5 pg/mL, 291.8 pg/mL, 89.4 pg/mL, P=0.05 and 0.02, respectively) during the acute phase. Serum IL-8 was not significantly different between the 3 groups. Nonetheless, no significant differences were found between the AP and Cys groups, in urinary or serum levels of IL-6 or IL-8, during both phases. Conclusion: IL-6 and IL-8 levels are elevated in patients with UTI. However, the levels did not differentiate between AP and cystitis. Further studies are warranted to evaluate their roles as indicators of the site of UTIs.

1 July 2006 in FEMS Immunology & Medical Microbiology
Verified
Journal Article
Open access
PDF file
RARaja'a Al-Attiyah
Raja'a Al-Attiyah
NMNada M. Madi
Nada M. Madi
AEAbdul-Salaam M. El-Shamy
Abdul-Salaam M. El-Shamy
HWHarald G. Wiker
Harald G. Wiker
PAPeter Andersen
Peter Andersen
AMAbu S. Mustafa
Abu S. Mustafa
Peripheral blood mononuclear cells (PBMC) were obtained from tuberculosis (TB) patients and Mycobacterium bovis bacillus Calmette–Guerin vaccinated he